Category

Insights
Canada’s Rare Disease Strategy – What is it and why do we care?

Canada’s Rare Disease Strategy – What is it and why do we care?

Approximately 1 in 12 Canadians, mostly children, are affected by a rare disorder. Patients with rare diseases face many challenges, including misdiagnosis, limited treatment, and difficulty accessing innovative therapies even when they are available. Implementing the Rare Disease Strategy will not necessarily cost Canadians more. Earlier diagnosis and correct treatments can lead to reduced unnecessary surgeries, organ transplants, and visits to multiple specialists, resulting in savings for the health system and taxpayers.

Value-based Health Care 

Value-based Health Care 

Reflecting over the last 2 years The pandemic has shown us the crucial imperative of having highly functioning and interconnected healthcare systems. Everything comes at a cost which is why it is so important to achieve the greatest value for money. But what is value...

Looking Forward To 2022 

Looking Forward To 2022 

Following the unprecedented year of 2020, 2021 brought increased global awareness to our field of work. The pandemic has brought terms such as ‘epidemiology’, ‘efficacy’ and ‘real word evidence’ into lay language and the vital role of health outcomes research has...

Looking Back On 2021

Looking Back On 2021

As the reality of living amongst a global pandemic set in across the world over the past year, a key highlight of 2021 was undoubtedly the rollout of life saving vaccines from AstraZeneca, Pfizer, Johnson and Johnson, and Moderna. At Medlior, this was also a year of...

COVID Vaccines in Canada

COVID Vaccines in Canada

COVID-19 has changed the entire world. In Medlior’s latest blog post, we look at vaccine development and approval in Canada, answering questions about how the vaccines could be developed so quickly, and what contributed to Canada’s slow start in rolling them out....

Key Highlights From ISPOR 2021

Key Highlights From ISPOR 2021

The ISPOR 2021 annual conference was held last week. As usual, there were numerous insightful and thought-provoking sessions and workshops to attend, aimed at improving health economics and outcomes research (HEOR) research methods. Unsurprisingly, the COVID-19...